Key statistics
On Tuesday, Actinogen Medical Ltd (ACW:ASX) closed at 0.024, 62.27% above the 52 week low of 0.0148 set on Oct 19, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.027 |
---|---|
High | 0.027 |
Low | 0.0235 |
Bid | 0.024 |
Offer | 0.025 |
Previous close | 0.027 |
Average volume | 12.34m |
---|---|
Shares outstanding | 2.71bn |
Free float | 2.28bn |
P/E (TTM) | -- |
Market cap | 73.24m AUD |
EPS (TTM) | -0.0061 AUD |
Data delayed at least 20 minutes, as of Sep 24 2024 07:10 BST.
More ▼
- Actinogen announces further positive results on depression in the XanCIDD phase 2a trial
- Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial
- Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau